Sunday, March 3, 2024
BestWooCommerceThemeBuilttoBoostSales-728x90

Trends in diabetes prevalence, awareness, treatment, and control in French-speaking Switzerland – Scientific Reports


  • Liu, J. et al. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health 20(1), 1415 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 390(10113):2627–42 (2017).

  • Lin, X. et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci. Rep. 10(1), 14790 (2020).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kotseva, K. et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur. J. Prev. Cardiol. 28(4), 370–379 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Lu, W. et al. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: A cross-sectional study. BMC Public Health 22(1), 883 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Estoppey, D., Paccaud, F., Vollenweider, P. & Marques-Vidal, P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997–2007. BMC Public Health 11, 114 (2011).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Mestral, C., Stringhini, S., Guessous, I. & Jornayvaz, F. R. Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: A population-based study. Diabet. Med. 37(8), 1374–1378 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • de Mestral, C., Stringhini, S., Guessous, I. & Jornayvaz, F. R. Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a Swiss population. BMJ Open Diabetes Res. Care 8(1), e001273 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gastaldi, G. et al. Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus. Swiss Med Wkly 153, 40060 (2023).

    Article 
    PubMed 

    Google Scholar
     

  • Cosentino, F. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 41(2), 255–323 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Roglic, G. & Norris, S. L. Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type 2 diabetes in low-resource settings: Synopsis of the world health organization guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus. Ann. Intern. Med. 169(6), 394–397 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Chu, C. H. et al. Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan. J. Formos. Med. Assoc. 118(Suppl 2), S74–S82 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Orlando, V. et al. Prescription patterns of antidiabetic treatment in the elderly. Results from Southern Italy. Curr. Diabetes Rev. 12(2), 100–106 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Kohro, T. et al. Trends in antidiabetic prescription patterns in Japan from 2005 to 2011. Int. Heart J. 54(2), 93–97 (2013).

    Article 
    PubMed 

    Google Scholar
     

  • Mata-Cases, M., Franch-Nadal, J., Real, J. & Mauricio, D. Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: A population-based study. BMJ Open. 6(10), e012463 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hampp, C., Borders-Hemphill, V., Moeny, D. G. & Wysowski, D. K. Use of antidiabetic drugs in the U.S. 2003–2012. Diabetes Care. 37(5), 1367–1374 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lipska, K. J. et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 40(4), 468–475 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Morabia, A., Bernstein, M., Heritier, S. & Ylli, A. Community-based surveillance of cardiovascular risk factors in Geneva: Methods, resulting distributions, and comparisons with other populations. Prev. Med. 26(3), 311–319 (1997).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Marques-Vidal, P. et al. Dietary intake according to gender and education: A twenty-year trend in a Swiss adult population. Nutrients 7(11), 9558–9572 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Humain CCdEdlRslê. CCER-obtenir une autorisation de recherche médicale sur l’être humain Republic and Canton of Geneva, Switzerland [updated 2023 Sept 12. Available from: https://www.ge.ch/ccer-obtenir-autorisation-recherche-medicale-etre-humain.

  • Magliano, D. J. et al. Trends in incidence of total or type 2 diabetes: Systematic review. BMJ. 366, l5003 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • (OFS) Ofdls. Inégalités sociales en santé physique Neuchâtel, Switzerland2020 [updated 2020 Oct 27. Available from: https://opendata.swiss/fr/dataset/soziale-ungleichheiten-und-korperliche-gesundheit.

  • Bahiru, E., Hsiao, R., Phillipson, D. & Watson, K. E. Mechanisms and treatment of dyslipidemia in diabetes. Curr. Cardiol. Rep. 23(4), 26 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Carson, A. P., Reynolds, K., Fonseca, V. A. & Muntner, P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 33(1), 95–97 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Khunti, S., Khunti, K. & Seidu, S. Therapeutic inertia in type 2 diabetes: Prevalence, causes, consequences and methods to overcome inertia. Ther. Adv. Endocrinol. Metab. 10, 2042018819844694 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ampudia-Blasco, F. J., Palanca, A., Trillo, J. L., Navarro, J. & Real, J. T. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents. J. Diabetes Complicat. 35(3), 107828 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Oraii, A. et al. Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study. BMC Endocr. Disord. 22(1), 248 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sun, Y., Ni, W., Yuan, X., Chi, H. & Xu, J. Prevalence, treatment, control of type 2 diabetes and the risk factors among elderly people in Shenzhen: Results from the urban Chinese population. BMC Public Health 20(1), 998 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ferrannini, G. et al. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: Results from the ESC-EORP EUROASPIRE surveys. Cardiovasc. Diabetol. 20(1), 38 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aa, K. Impact of gender on type II diabetes glycemic and cardiovascular markers control and treatment. Pak. J. Biol. Sci. 23(12), 1643–1649 (2020).

    Article 

    Google Scholar
     

  • Alhagawy, A. J. et al. Barriers and attitudes of primary healthcare physicians to insulin initiation and intensification in Saudi Arabia. Int. J. Environ. Res. Public Health 19(24), 16794 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zafar, A., Stone, M. A., Davies, M. J. & Khunti, K. Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: A qualitative study. Diabet. Med. 32(3), 407–413 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Safari-Faramani, R. et al. Prevalence, awareness, treatment, control, and the associated factors of diabetes in an Iranian Kurdish population. J. Diabetes Res. 2019, 5869206 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guh, D. P. et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 9, 88 (2009).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sonmez, A. et al. Impact of obesity on the metabolic control of type 2 diabetes: Results of the Turkish nationwide survey of glycemic and other metabolic parameters of patients with diabetes mellitus (TEMD Obesity Study). Obes. Facts. 12(2), 167–178 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • White, J. R. Jr. A brief history of the development of diabetes medications. Diabetes Spectr. 27(2), 82–86 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Braunwald, E. SGLT2 inhibitors: The statins of the 21st century. Eur. Heart J. 43(11), 1029–1030 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nauck, M. A., Quast, D. R., Wefers, J. & Meier, J. J. GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art. Mol. Metab. 46, 101102 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ali, S. N., Dang-Tan, T., Valentine, W. J. & Hansen, B. B. Evaluation of the Clinical and economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the United States. Adv. Ther. 37(2), 869–882 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bain, S. C., Bekker Hansen, B., Hunt, B., Chubb, B. & Valentine, W. J. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. J. Med. Econ. 23(1), 98–105 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Palmer, S. C. et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials. BMJ 372, m4573 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Groupe de travail de la SGED/SSED: Roger Lehmann (Chair) GG, Astrid Czock, Marc Egli, Doris Fischer-Taeschler, Markus Laimer, Barbara Lucchini, Sebastien Thalmann, Peter Wiesli Recommandations de la Société Suisse d’Endocrinologie et de Diabétologie (SGED-SSED) pour le traitement du diabète de type 2 (2020) Switzerland2020 [Available from: https://www.sgedssed.ch/fileadmin/user_upload/6_Diabetologie/61_Empfehlungen_Facharzt/2020_Swiss_Recomm_Medis_FR_def.pdf.

  • Stirratt, M. J. et al. Self-report measures of medication adherence behavior: Recommendations on optimal use. Transl. Behav. Med. 5(4), 470–482 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    [td_block_social_counter facebook="beingmedicos1" twitter="being_medicos" youtube="beingmedicosgroup" style="style8 td-social-boxed td-social-font-icons" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjM4IiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3Njh9" custom_title="Stay Connected" block_template_id="td_block_template_8" f_header_font_family="712" f_header_font_transform="uppercase" f_header_font_weight="500" f_header_font_size="17" border_color="#dd3333"]
    - Advertisement -spot_img

    Latest Articles